Insight journal - Company

Cubist: M&A activity 2009-2014

Posted on 17 March 2014

Cubist has acquired a few companies in the last five years with its biggest purchase of $800 million of Optimer Pharmaceuticals.      

Abstracted from: Report: Partnering Agreements with Cubist 2009-2014

Cubist is involved in M&A activity for growth similar to its peers in the list of top biopharmaceutical companies. Cubist has on occasions sought growth through strategic acquisition, for example when acquiring Trius Therapeutics and Opimer Pharmaceuticals. Cubist acquired Trius Therapeutics that was working on a late stage compound for MRSA treatment. Similary, Optimer was then working on fidamoxicin, a macrocyclic antibiotic drug and later bought by Cubist in a high value acquisition.

The following figure shows the level of Cubist M&A deal announcements since 2009.

Figure 1: Cubist M&A deals 2009-2014

Figure 1: Cubist M&A deals 2009-2014

Figure 1: Cubist M&A deals 2009-2014

Source: Current Agreements, 2014

Cubist has signed 4 M&A deals since 2009. Companies acquired include:

  • Optimer Pharmaceuticals
  • Trius Therapeutics
  • Adolor
  • Calixa

View the full list at Current Agreements (subscription required)

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Cubist M&A deals by headline value 2009-2014

Figure 2: Top Cubist M&A deals by headline value 2009-2014

Figure 2: Top Cubist M&A deals by headline value 2009-2014

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal. See: Report: Partnering Agreements with Cubist 2009-2014

Cubist M&A at Current Agreements                       

View all M&A deals for Cubist: 2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Report: Partnering Agreements with Cubist 2009-2014

More

Summary profile data for Cubist

Partnering interests for Cubist 

Partnering activity for Cubist

 

Available reports from Current Partnering

Report: Partnering Agreements with Cubist 2009-2014

Report: Partnering Deals and Alliances with Big Biotech

 

Available resources for deal coverage for Cubist           

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Cubist company profile, recent partnering, M&A and financing news and articles

 

Related

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

 

 

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new2gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
e80banner300x150animgif
a1banner300x150animgif